Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Gastric Cancer

  Free Subscription

Articles published in Cancer Lett

Retrieve available abstracts of 70 articles:
HTML format

Single Articles

    June 2021
  1. MILIOTIS C, Slack FJ
    miR-105-5p regulates PD-L1 expression and tumor immunogenicity in gastric cancer.
    Cancer Lett. 2021 Jun 4. pii: S0304-3835(21)00268.
    PubMed     Abstract available

    December 2020
  2. DAVERN M, Lysaght J
    Cooperation between chemotherapy and immunotherapy in gastroesophageal cancers.
    Cancer Lett. 2020;495:89-99.
    PubMed     Abstract available

    October 2020
  3. ZHU S, Khalafi S, Chen Z, Poveda J, et al
    Silencing of miR490-3p by H. pylori activates DARPP-32 and induces resistance to gefitinib.
    Cancer Lett. 2020;491:87-96.
    PubMed     Abstract available

  4. TANG H, Kong Y, Guo J, Tang Y, et al
    Corrigendum to "Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22" [Canc. Lett. 340 (1) (Oct 28, 2013) 72-81].
    Cancer Lett. 2020 Oct 5. pii: S0304-3835(20)30356.

    September 2020
  5. YANG J, Liu Z, Zeng B, Hu G, et al
    Epstein-Barr virus-associated gastric cancer: A distinct subtype.
    Cancer Lett. 2020 Sep 23. pii: S0304-3835(20)30486.
    PubMed     Abstract available

  6. MA DH, Li BS, Liu JJ, Xiao YF, et al
    Corrigendum to 'miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway'[Cancer Lett. 2017 Nov 1;408:23-32].
    Cancer Lett. 2020 Sep 22. pii: S0304-3835(20)30470.

    August 2020
  7. ZENG Y, Ren M, Li Y, Liu Y, et al
    Knockdown of RhoGDI2 represses human gastric cancer cell proliferation, invasion and drug resistance via the Rac1/Pak1/LIMK1 pathway.
    Cancer Lett. 2020 Aug 26. pii: S0304-3835(20)30368.
    PubMed     Abstract available

  8. LIU Y, Zhang X, Zhang Y, Hu Z, et al
    Corrigendum to "Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer"[Canc. Lett. 369 (2015) 58-66].
    Cancer Lett. 2020;494:3-4.

    July 2020
  9. XIE S, Chang Y, Jin H, Feng Y, et al
    Non-coding RNAs in gastric cancer.
    Cancer Lett. 2020 Jul 23. pii: S0304-3835(20)30352.
    PubMed     Abstract available

    April 2020
  10. WANG J, Wu X, Dai W, Li J, et al
    The CCDC43-ADRM1 axis regulated by YY1, promotes proliferation and metastasis of gastric cancer.
    Cancer Lett. 2020 Apr 8. pii: S0304-3835(20)30159.
    PubMed     Abstract available

    March 2020
  11. WANG Y, Lu JH, Wang F, Wang YN, et al
    Inhibition of fatty acid catabolism augments the efficacy of oxaliplatin-based chemotherapy in gastrointestinal cancers.
    Cancer Lett. 2020;473:74-89.
    PubMed     Abstract available

  12. TAM BY, Chiu K, Chung H, Bossard C, et al
    The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models.
    Cancer Lett. 2020;473:186-197.
    PubMed     Abstract available

  13. ZHAO M, Hou Y, Du YE, Yang L, et al
    Drosha-independent miR-6778-5p strengthens gastric cancer stem cell stemness via regulation of cytosolic one-carbon folate metabolism.
    Cancer Lett. 2020 Mar 3. pii: S0304-3835(20)30109.
    PubMed     Abstract available

    February 2020
  14. PAN H, Pan J, Chen P, Gao J, et al
    Circular RNA circUBA1 promotes gastric cancer proliferation and metastasis by acting as a competitive endogenous RNA through sponging miR-375 and regulating TEAD4.
    Cancer Lett. 2020 Feb 19. pii: S0304-3835(20)30085.
    PubMed     Abstract available

    January 2020
  15. BAROK M, Le Joncour V, Martins A, Isola J, et al
    ARX788, a novel anti-HER2 antibody-drug conjugate, shows anti-tumor effects in preclinical models of trastuzumab emtansine-resistant HER2-positive breast cancer and gastric cancer.
    Cancer Lett. 2020 Jan 2. pii: S0304-3835(19)30659.
    PubMed     Abstract available

    December 2019
  16. LU J, Wang YH, Yoon C, Huang XY, et al
    Circular RNA circ-RanGAP1 regulates VEGFA expression by targeting miR-877-3p to facilitate gastric cancer invasion and metastasis.
    Cancer Lett. 2019 Dec 4. pii: S0304-3835(19)30602.
    PubMed     Abstract available

    October 2019
  17. TELLI TA, Bregni G, Camera S, Deleporte A, et al
    PD-1 and PD-L1 inhibitors in oesophago-gastric cancers.
    Cancer Lett. 2019 Oct 25. pii: S0304-3835(19)30539.
    PubMed     Abstract available

    June 2019
  18. LV Y, Zhou D, Hao XQ, Zhu MY, et al
    A Recombinant Measles Virus Vaccine Strain rMV-Hu191 Has Oncolytic Effect against Human Gastric Cancer by Inducing Apoptotic Cell Death Requiring Integrity of Lipid Raft Microdomains.
    Cancer Lett. 2019 Jun 18. pii: S0304-3835(19)30371.
    PubMed     Abstract available

  19. LIU X, Lu Y, Xu Y, Hou S, et al
    Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer.
    Cancer Lett. 2019 Jun 4. pii: S0304-3835(19)30330.
    PubMed     Abstract available

    May 2019
  20. YUAN J, Yin Z, Tan L, Zhu W, et al
    Interferon regulatory factor-1 reverses chemoresistance by downregulating the expression of P-glycoprotein in gastric cancer.
    Cancer Lett. 2019 May 9. pii: S0304-3835(19)30282.
    PubMed     Abstract available

  21. HU Y, Qi C, Liu X, Zhang C, et al
    Malignant ascites-derived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer.
    Cancer Lett. 2019 May 7. pii: S0304-3835(19)30271.
    PubMed     Abstract available

    April 2019
  22. ZHAI J, Shen J, Xie G, Wu J, et al
    Cancer-associated Fibroblasts-derived IL-8 Mediates Resistance to Cisplatin in Human Gastric Cancer.
    Cancer Lett. 2019 Apr 9. pii: S0304-3835(19)30227.
    PubMed     Abstract available

    March 2019
  23. ZHAO C, Tao T, Yang L, Qin Q, et al
    Loss of PDZK1 expression activates PI3K/AKT signaling via PTEN phosphorylation in gastric cancer.
    Cancer Lett. 2019 Mar 28. pii: S0304-3835(19)30199.
    PubMed     Abstract available

  24. DU F, Feng W, Chen S, Wu S, et al
    Sex determining region Y-box 12 (SOX12) promotes gastric cancer metastasis by upregulating MMP7 and IGF1.
    Cancer Lett. 2019 Mar 25. pii: S0304-3835(19)30191.
    PubMed     Abstract available

  25. ZHANG B, Ling T, Zhaxi P, Cao Y, et al
    Proton pump inhibitor pantoprazole inhibits gastric cancer metastasis via suppression of telomerase reverse transcriptase gene expression.
    Cancer Lett. 2019;452:23-30.
    PubMed     Abstract available

  26. HU Y, Liu JP, Li XY, Cai Y, et al
    Downregulation of tumor suppressor RACK1 by Helicobacter pylori infection promotes gastric carcinogenesis through the integrin beta-1/NF-kappaB signaling pathway.
    Cancer Lett. 2019 Mar 5. pii: S0304-3835(19)30125.
    PubMed     Abstract available

    February 2019
  27. XU Z, Li Z, Wang W, Xia Y, et al
    MIR-1265 regulates cellular proliferation and apoptosis by targeting calcium binding protein 39 in gastric cancer and, thereby, impairing oncogenic autophagy.
    Cancer Lett. 2019 Feb 16. pii: S0304-3835(19)30104.
    PubMed     Abstract available

  28. WANG Y, Wang K, Jin Y, Sheng X, et al
    Endoplasmic reticulum proteostasis control and gastric cancer.
    Cancer Lett. 2019 Feb 15. pii: S0304-3835(19)30054.
    PubMed     Abstract available

  29. KOEMANS WJ, Chalabi M, van Sandick JW, van Dieren JM, et al
    Beyond the PD-L1 horizon: In search for a good biomarker to predict success of immunotherapy in gastric and esophageal adenocarcinoma.
    Cancer Lett. 2019;442:279-286.
    PubMed     Abstract available

    December 2018
  30. GUO H, Ji F, Zhao X, Yang X, et al
    MicroRNA-371a-3p Promotes Progression of Gastric Cancer by Targeting TOB1.
    Cancer Lett. 2018 Dec 4. pii: S0304-3835(18)30687.
    PubMed     Abstract available

    November 2018
  31. XIE M, Ma T, Xue J, Ma H, et al
    The long intergenic non-protein coding RNA 707 promotes proliferation and metastasis of gastric cancer by interacting with mRNA stabilizing protein HuR.
    Cancer Lett. 2018 Nov 28. pii: S0304-3835(18)30698.
    PubMed     Abstract available

  32. FANG J, Hong H, Xue X, Zhu X, et al
    A novel circular RNA, circFAT1(e2), inhibits gastric cancer progression by targeting miR-548g in the cytoplasm and interacting with YBX1 in the nucleus.
    Cancer Lett. 2018 Nov 9. pii: S0304-3835(18)30661.
    PubMed     Abstract available

    May 2018
  33. DING M, Wang H, Qu C, Xu F, et al
    Pyrazolo[1,5-a]pyrimidine TRPC6 Antagonists for the Treatment of Gastric Cancer.
    Cancer Lett. 2018 May 31. pii: S0304-3835(18)30380.
    PubMed     Abstract available

  34. MIN A, Eun Kim J, Kim YJ, Min Lim J, et al
    Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells.
    Cancer Lett. 2018 May 2. pii: S0304-3835(18)30310.
    PubMed     Abstract available

    February 2018
  35. ESPINOZA JL, Matsumoto A, Tanaka H, Matsumura I, et al
    Gastric microbiota: An emerging player in Helicobacter pylori-induced gastric malignancies.
    Cancer Lett. 2018;414:147-152.
    PubMed     Abstract available

    January 2018
  36. QIAO Y, Li T, Zheng S, Wang H, et al
    The Hippo pathway as a drug target in gastric cancer.
    Cancer Lett. 2018 Jan 30. pii: S0304-3835(18)30095.
    PubMed     Abstract available

  37. MANU KA, Shanmugam MK, Ramachandran L, Li F, et al
    Corrigendum on "Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-kappaB signaling cascade in gastric cancer" [Cancer Lett. 363 (1) (2015) 28-36].
    Cancer Lett. 2018 Jan 13. pii: S0304-3835(18)30025.

  38. YUAN H, Chen Z, Bai S, Wei H, et al
    Molecular mechanisms of lncRNA SMARCC2/miR-551b-3p/TMPRSS4 axis in gastric cancer.
    Cancer Lett. 2018 Jan 11. pii: S0304-3835(18)30054.
    PubMed     Abstract available

    November 2017
  39. YANG L, Zhang W, Wang Y, Zou T, et al
    Hypoxia-induced miR-214 expression promotes tumour cell proliferation and migration by enhancing the Warburg effect in gastric carcinoma cells.
    Cancer Lett. 2017 Nov 9. pii: S0304-3835(17)30701.
    PubMed     Abstract available

    October 2017
  40. ZENG S, Xie X, Xiao YF, Tang B, et al
    Long noncoding RNA LINC00675 enhances phosphorylation of vimentin on Ser83 to suppress gastric cancer progression.
    Cancer Lett. 2017;412:179-187.
    PubMed     Abstract available

  41. DAS K, Taguri M, Imamura H, Sugimoto N, et al
    Genomic Predictors of Chemotherapy Efficacy in Advanced or Recurrent Gastric Cancer in the GC0301/ TOP002 Phase III Clinical Trial.
    Cancer Lett. 2017 Oct 20. pii: S0304-3835(17)30645.
    PubMed     Abstract available

  42. WU QN, Liao YF, Lu YX, Wang Y, et al
    Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance.
    Cancer Lett. 2017 Oct 16. pii: S0304-3835(17)30631.
    PubMed     Abstract available

  43. CHEN J, Li GQ, Zhang L, Tang M, et al
    Complement C5a/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression.
    Cancer Lett. 2017 Oct 12. pii: S0304-3835(17)30626.
    PubMed     Abstract available

  44. GUO W, You X, Wang X, Wang L, et al
    A synthetic peptide hijacks the catalytic subunit of class I PI3K to suppress the growth of cancer cells.
    Cancer Lett. 2017;405:1-9.
    PubMed     Abstract available

    September 2017
  45. LI B, Wang W, Li Z, Chen Z, et al
    MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression.
    Cancer Lett. 2017 Sep 28. pii: S0304-3835(17)30596.
    PubMed     Abstract available

  46. LI Y, Huang S
    Response to Comment on response to "Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer," Cancer Lett. 2017 Mar 1; 388(2017): 208-219.
    Cancer Lett. 2017 Sep 26. pii: S0304-3835(17)30553.

    August 2017
  47. ZHANG J, Zhu J
    Comment on response to "Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer," Cancer Lett. 2017 Mar 1; 388(2017): 208-219.
    Cancer Lett. 2017 Aug 26. pii: S0304-3835(17)30505.

  48. MA DH, Li BS, Liu JJ, Xiao YF, et al
    miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway.
    Cancer Lett. 2017 Aug 24. pii: S0304-3835(17)30504.
    PubMed     Abstract available

  49. WANG ZQ, He CY, Hu L, Shi HP, et al
    Long noncoding RNA UCA1 promotes tumour metastasis by inducing GRK2 degradation in gastric cancer.
    Cancer Lett. 2017 Aug 23. pii: S0304-3835(17)30490.
    PubMed     Abstract available

  50. NORONHA V, Patil VM, Joshi A, Chougule A, et al
    Potential role of metronomic chemotherapy in the treatment of esophageal and gastroesophageal cancer.
    Cancer Lett. 2017;400:267-275.
    PubMed     Abstract available

    July 2017
  51. RIBEIRO J, Malta M, Galaghar A, Silva F, et al
    P53 deregulation in Epstein-Barr virus-associated gastric cancer.
    Cancer Lett. 2017;404:37-43.
    PubMed     Abstract available

    June 2017
  52. DENG M, Zeng C, Lu X, He X, et al
    miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
    Cancer Lett. 2017 Jun 17. pii: S0304-3835(17)30387.
    PubMed     Abstract available

    May 2017
  53. LI Y, Huang S
    Response to "Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer," Cancer Lett. 2017 Mar 1; 388(2017): 208-219.
    Cancer Lett. 2017 May 30. pii: S0304-3835(17)30330.

  54. SUN Z, Liu J, Zhou Q, Yang S, et al
    Comment on "Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer," Cancer Lett. 2017 Mar 1; 388(2017): 208-219.
    Cancer Lett. 2017 May 20. pii: S0304-3835(17)30331.

    April 2017
  55. GEN Y, Yasui K, Kitaichi T, Iwai N, et al
    ASPP2 suppresses invasion and TGF-beta1-induced epithelial-mesenchymal transition by inhibiting Smad7 degradation mediated by E3 ubiquitin ligase ITCH in gastric cancer.
    Cancer Lett. 2017 Apr 8. pii: S0304-3835(17)30232.
    PubMed     Abstract available

    March 2017
  56. LI Y, Wu Z, Yuan J, Sun L, et al
    Long non-coding RNA MALAT1 promotes gastric cancer tumorigenicity and metastasis by regulating vasculogenic mimicry and angiogenesis.
    Cancer Lett. 2017 Mar 4. pii: S0304-3835(17)30152.
    PubMed     Abstract available

    February 2017
  57. FERREIRA JA, Magalhaes A, Gomes J, Peixoto A, et al
    Protein glycosylation in gastric and colorectal cancers: Toward cancer detection and targeted therapeutics.
    Cancer Lett. 2017;387:32-45.
    PubMed     Abstract available

  58. XU L, Zhou R, Yuan L, Wang S, et al
    IGF1/IGF1R/STAT3 signaling-inducible IFITM2 promotes gastric cancer growth and metastasis.
    Cancer Lett. 2017 Feb 18. pii: S0304-3835(17)30122.
    PubMed     Abstract available

  59. WU H, Liu S, Gong J, Liu J, et al
    VCPA, a novel synthetic derivative of alpha-tocopheryl succinate, sensitizes human gastric cancer to doxorubicin-induced apoptosis via ROS-dependent mitochondrial dysfunction.
    Cancer Lett. 2017 Feb 16. pii: S0304-3835(17)30107.
    PubMed     Abstract available

    January 2017
  60. TSAI MM, Wang CS, Tsai CY, Chen CY, et al
    Corrigendum to "MicroRNA-196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer" [Cancer Lett 351 (2014) 222-231].
    Cancer Lett. 2017 Jan 27. pii: S0304-3835(17)30071.

    December 2016
  61. MI Y, Zhang D, Jiang W, Weng J, et al
    miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation.
    Cancer Lett. 2016 Dec 30. pii: S0304-3835(16)30803.
    PubMed     Abstract available

  62. CHEN J, Li Y, Zheng Q, Bao C, et al
    Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer.
    Cancer Lett. 2016;388:208-219.
    PubMed     Abstract available

    November 2016
  63. YUAN W, Liu B, Wang X, Li T, et al
    CMTM3 decreases EGFR expression and EGF-mediated tumorigenicity by promoting Rab5 activity in gastric cancer.
    Cancer Lett. 2016 Nov 17. pii: S0304-3835(16)30703.
    PubMed     Abstract available

  64. LI R, Liu B, Gao J
    The application of nanoparticles in diagnosis and theranostics of gastric cancer.
    Cancer Lett. 2016 Nov 11. pii: S0304-3835(16)30663.
    PubMed     Abstract available

  65. WANG Z, Wang Z, Li G, Wu H, et al
    CXCL1 from tumor-associated lymphatic endothelial cells drives gastric cancer cell into lymphatic system via activating integrin beta1/FAK/AKT signaling.
    Cancer Lett. 2016;385:28-38.
    PubMed     Abstract available

    October 2016
  66. HWANG DW, Bang NY, Ito K, Ha S, et al
    In vivo targeting of c-Met using a non-standard macrocyclic peptide in gastric carcinoma.
    Cancer Lett. 2016 Oct 31. pii: S0304-3835(16)30661.
    PubMed     Abstract available

  67. PENG Y, Zhang X, Ma Q, Yan R, et al
    MiRNA-194 activates the Wnt/beta-catenin signaling pathway in gastric cancer by targeting the negative Wnt regulator, SUFU.
    Cancer Lett. 2016 Oct 31. pii: S0304-3835(16)30666.
    PubMed     Abstract available

  68. WANG JB, Wang ZW, Li Y, Huang CQ, et al
    CDK5RAP3 acts as a tumor suppressor in gastric cancer through inhibition of beta-catenin signaling.
    Cancer Lett. 2016 Oct 25. pii: S0304-3835(16)30645.
    PubMed     Abstract available

    July 2016
  69. DU Y, Yu J, Du L, Tang J, et al
    Cordycepin enhances Epstein-Barr virus lytic infection and Epstein-Barr virus-positive tumor treatment efficacy by doxorubicin.
    Cancer Lett. 2016;376:240-8.
    PubMed     Abstract available

    June 2016
  70. HOU J, Wang T, Xie Q, Deng W, et al
    N-Myc-interacting protein (NMI) negatively regulates epithelial-mesenchymal transition by inhibiting the acetylation of NF-kappaB/p65.
    Cancer Lett. 2016;376:22-33.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.